Company profile

Dexcom Inc Insider Trading

DXCM

Every SEC Form 4 insider trading filing for Dexcom Inc (DXCM) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
CIK
0001093557
Filings
215
Insiders
27
Last filing
2026-08-14

Activity summary

No discretionary insider buying or selling in the last 30 days. Of the 5 transactions filed, 4 were scheduled under a 10b5-1 plan and 1 was grants, option exercises or other non-open-market activity.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. Dexcom Inc insiders are net sellers across the period shown.

Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $27.7M.

90 day insight

Over the last 90 days, Dexcom Inc insiders bought $0 across 10 transactions with no open-market sales.

  • Most active insider: Foletta Mark G with 5 transactions totaling $627K.
  • Largest single sale: $2.0M by Sayer Kevin R on Jul 20, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 14, 2026Brown Michael JonDXCM
Sale10b5
1,700$91.93$156K
Aug 12, 2026Augustinos NicholasDXCM
Gift
1,075
Aug 12, 2026Heller Bridgette PDXCM
Sale10b5
1,012$88.29$89K
Aug 3, 2026Foletta Mark GDXCM
Sale10b5
2,000$85.32$171K
Jul 31, 2026Foletta Mark GDXCM
Sale10b5
2,000$80.00$160K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=DXCM" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Sayer Kevin RExecutive Chair4 filings$8.1M
Leach Jacob StevenEVP Chief Technology Officer2 filings$1.4M
Sylvain Jereme MEVP Chief Financial Officer2 filings$1.4M
Stern SadieEVP Chief Human Resources Offi2 filings$1.3M
Coleman JonEVP, Chief Commercial Officer3 filings$1.3M

Institutional Ownership

Top 13F-HR holders of Dexcom Inc as of 2026-06-30

↓ decreasing
Total reported AUM
$7.75B
QoQ change
-62.6%
Reporting period
2026-06-30
#1
State Street Corp
CIK 0000093751
$1.24B
18.4M shares
#2
BlackRock, Inc.
CIK 0002012383
$1.14B
16.9M shares
#3
Baillie Gifford & Co
CIK 0001088875
$541.4M
8.0M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →